Skip to main content
. 2022 Mar 29;23:76. doi: 10.1186/s12931-022-01997-9

Table 1.

Pro-inflammatory cytokines measured in BAL fluid and lung homogenate of vitamin D sufficient or deficient mice treated either with vehicle or 1α,25(OH)2D3 followed by LPS. Interleukin (IL), Tumor necrosis factor-α (TNF-α) and interferon-γ (IFN-γ) expressed as pg/ml for BAL fluid and pg/µg for lung homogenate

BAL LUNG
Sufficient Deficient Sufficient Deficient
Vehicle 1α,25(OH)2D3 Vehicle 1α,25(OH)2D3 Vehicle 1α,25(OH)2D3 Vehicle 1α,25(OH)2D3
IL-1β 29.7 (22.2–33.1) 25.7 (16.4–29.4) 42.9 (31.5–52.1) +  30.4 (11.7–46.7) 8802 (3366–19,353) 5595 (2883–15,263) 4590 (3514–16,624) 4799 (659–11,665)
IL-6 5603 (3747–7703) 3983 (2241–4562) 3795 (1787–8395) 3027 (537–7070) 1878 (755–2811) 1397 (600–6790) 5731 (851–18,101) 1125 (307–2454)
IL-10 9.8 (6.4–13.3) 7.5 (6.6–13.7) 18.7 (11.8–68.0) 14.5 (9.7–33.5) 30.6 (14.5–49.8) 39.5 (15.9–47.5) 71.4 (17.8–179) 14.9 (5.6–38.1)
IL-13 15.4 (13.7–19.3) 13.9 (11.3–17.7) 20.9 (16.4–30.5)* 14.8 (12.2–16.0)## 88.2 (36.6–112) 80.2 (29.8–131.7) 135 (93.4–201.4) +  34.1 (14.4–53.7)#
IL-17A 0.8 (0.6–1.2) 1.2 (0.5–2.8) 1.4 (0.5–3.2) 0.6 (0.3–1.2) 3.9 (2.7–5.6) 3.7 (0.9–19.7) 5.9 (2.6–24) 2.4 (1.2–5.9)
TNF-⍺ 987 (682–1223) 811 (405–1152) 1036 (505–1459) 1115 (550–1373) 915 (434–1881) 736 (302–1529) 946 (550–2161) 591 (148–1051)
IFN-γ 2.34 (0.76–3.97) 2.98 (0.37–16.53) 1.16 (0.57–8.28) 1.03 (0.34–18.47) 3.9 (1.6–6.3) 3.2 (1.2–24.7) 3.8 (2.6–9.1) 2.5 (0.7–14.3)

*: p < 0.05 vehicle deficient vs vehicle sufficient (Kruskal–Wallis); #: p < 0.05 1α,25(OH)2D3 deficient vs vehicle deficient (Kruskal–Wallis); + : p < 0.05 vehicle deficient vs vehicle sufficient (Mann Whitney); ##: p < 0.01 1α,25(OH)2D3 deficient vs vehicle deficient (Mann Whitney). Data are expressed as Median ± IQR, with n = 7/group (VDS) n = 11 (vehicle-VDD) and n = 9 (1α,25(OH)2D3-VDD) for measurements in BAL and n = 6/group for measurements in lung